4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,165.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 1,820.00p
  • 52 Week Low: 930.00p
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 2,156
  • Market Cap: £180.53m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
86.33% above the market average86.33% above the market average86.33% above the market average86.33% above the market average86.33% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
97.35% above the market average97.35% above the market average97.35% above the market average97.35% above the market average97.35% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
46.05% above the market average46.05% above the market average46.05% above the market average46.05% above the market average46.05% above the market average
67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average
Price Chg 3m
3.15% below the market average3.15% below the market average3.15% below the market average3.15% below the market average3.15% below the market average
10.20% above the sector average10.20% above the sector average10.20% above the sector average10.20% above the sector average10.20% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
83.67% above the market average83.67% above the market average83.67% above the market average83.67% above the market average83.67% above the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average
Momentum 20
94.70% above the market average94.70% above the market average94.70% above the market average94.70% above the market average94.70% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
93.35% below the market average93.35% below the market average93.35% below the market average93.35% below the market average93.35% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
46.01% below the market average46.01% below the market average46.01% below the market average46.01% below the market average46.01% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
86.7% below the market average86.7% below the market average86.7% below the market average86.7% below the market average86.7% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Operating Profit Loss
80.63% below the market average80.63% below the market average80.63% below the market average80.63% below the market average80.63% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
52.45% below the market average52.45% below the market average52.45% below the market average52.45% below the market average52.45% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Cash
33.03% below the market average33.03% below the market average33.03% below the market average33.03% below the market average33.03% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
16.01% above the market average16.01% above the market average16.01% above the market average16.01% above the market average16.01% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Buys 1y
69.93% above the market average69.93% above the market average69.93% above the market average69.93% above the market average69.93% above the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,165.00p
Change Today 35.00p
% Change 3.10 %
52 Week High 1,820.00p
52 Week Low 930.00p
Volume 2,156
Shares Issued 15.50m
Market Cap £180.53m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.09% below the market average23.09% below the market average23.09% below the market average23.09% below the market average23.09% below the market average
29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average
Price Trend
55.36% above the market average55.36% above the market average55.36% above the market average55.36% above the market average55.36% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Income Not Available
Growth
37.90% above the market average37.90% above the market average37.90% above the market average37.90% above the market average37.90% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

4basebio Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
16:02 455 @ 1,150.00p
13:44 500 @ 1,130.00p
10:53 500 @ 1,150.00p
09:41 700 @ 1,150.00p
08:30 1 @ 1,150.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page